Sanara MedTech (SMTI) investor relations material

Board of directors and corporate governance

• Sara N. Ortwein will be appointed as Lead Independent Director for a three-year term, contingent on her election at the Annual Meeting, with additional annual compensation of $40,000.

• The Lead Independent Director's duties include preparing and reviewing Board meeting agendas and minutes, handling board issues, and presiding over executive sessions.

• Rozell Mack III will become chair of the Compensation Committee, contingent on his election, while Ms. Ortwein will remain a committee member.

• Ronald T. Nixon's title will change from Executive Chairman to Chairman, effective as of the Annual Meeting and contingent on his election.

Voting matters and shareholder proposals

• The supplement amends the previously filed Proxy Statement for the 2026 Annual Meeting scheduled for June 4, 2026.

• All previously distributed proxy cards remain valid; no new proxy card or voting instructions are required unless shareholders wish to change their vote.

• Shareholders may revoke or change their proxy vote as described in the Proxy Statement.

Executive compensation and say-on-pay

• The Lead Independent Director will receive an additional annual cash payment of $40,000, paid quarterly, for her service.